Increased requirement for platelet transfusions concurrent with enhanced bleeding during romiplostim treatment in a patient with thrombocytopenia due to bone marrow failure

Ann Hematol. 2011 Nov;90(11):1357-9. doi: 10.1007/s00277-011-1180-9. Epub 2011 Feb 16.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Anemia, Aplastic / complications*
  • Anemia, Aplastic / therapy*
  • Female
  • Hemorrhage / etiology*
  • Hemorrhage / therapy
  • Humans
  • Middle Aged
  • Platelet Transfusion*
  • Receptors, Fc / therapeutic use*
  • Recombinant Fusion Proteins / adverse effects*
  • Recombinant Fusion Proteins / therapeutic use*
  • Thrombocytopenia* / complications
  • Thrombocytopenia* / drug therapy
  • Thrombocytopenia* / etiology
  • Thrombopoietin / adverse effects*
  • Thrombopoietin / therapeutic use*

Substances

  • Receptors, Fc
  • Recombinant Fusion Proteins
  • Thrombopoietin
  • romiplostim